The Protein C Pathway: New Insights

Charles T Esmon; Wei Ding; Katsuura Yasuhiro; Jian-Ming Gu; Gary Ferrell; Lisa M Regan; Deborah J Stearns-Kurosawa; Shimichiro Kurosawa; Timothy Mather; Zolton Laszik; Naomi L Esmon

doi:10.1055/s-0038-1657503

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1997; 78(01): 070-074
DOI: 10.1055/s-0038-1657503

The protein C pathway

Schattauer GmbH Stuttgart

The Protein C Pathway: New Insights

Charles T Esmon

¹Oklahoma Medical Research Foundation, Oklahoma City, OK, USA

²Department of Biochemistry and Molecular Biology, Oklahoma City, OK, USA

³Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

⁴Howard Hughes Medical Institute, Oklahoma City, OK, USA

,

Wei Ding

²Department of Biochemistry and Molecular Biology, Oklahoma City, OK, USA

,

Katsuura Yasuhiro

¹Oklahoma Medical Research Foundation, Oklahoma City, OK, USA

,

Jian-Ming Gu

⁴Howard Hughes Medical Institute, Oklahoma City, OK, USA

,

Gary Ferrell

⁴Howard Hughes Medical Institute, Oklahoma City, OK, USA

,

Lisa M Regan

⁴Howard Hughes Medical Institute, Oklahoma City, OK, USA

,

Deborah J Stearns-Kurosawa

¹Oklahoma Medical Research Foundation, Oklahoma City, OK, USA

,

Shimichiro Kurosawa

¹Oklahoma Medical Research Foundation, Oklahoma City, OK, USA

,

Timothy Mather

¹Oklahoma Medical Research Foundation, Oklahoma City, OK, USA

,

Zolton Laszik

³Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

,

Naomi L Esmon

¹Oklahoma Medical Research Foundation, Oklahoma City, OK, USA

³Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

› Author Affiliations

Abstract

PDF Download

PDF (989 kb)

References

References
1 Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743-4746
2 Dreyfus M, Magny JF, Bridey F, Schwarz HP, Planché C, Dehan M, Tchernia G. Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 1991; 325: 1565-1568
3 Dahlbäck B. Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism. J Clin Invest 1994; 94: 923-927
4 Ohlin A-K, Marlar RA. The first mutation identified in the thrombomodulin gene in a 45-year-old man presenting with thromboembolic disease. Blood 1995; 85 (02) 330-336
5 Healy AM, Rayburn HB, Rosenberg RD, Weiler H. Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc Natl Acad Sci (USA) 1995; 92: 850-854
6 Cortellaro M, Boschetti C, Cofrancesco E, Zanussi C, Catalano M, de Gaetano G, Gabrielli L, Lombardi B, Specchia G, Tavazzi L. et al The PLAT Study: Hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. Arterioscl Thromb 1992; 12: 1063-1070
7 Gruber A, Griffin JH, Harker LA, Hanson SR. Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model. Blood 1989; 73: 639-642
8 Hanson SR, Griffin JH, Harker LA, Kelly AB, Esmon CT, Gruber A. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. J Clin Invest 1993; 92: 2003-2012
9 De Stefano V, Mastrangelo S, Schwarz HP, Pola P, Flore R, Bizzi B, Leone G. Replacement therapy with a purified protein C concentrate during initiation of oral anticoagulation in severe protein C congenital deficiency. Thromb Haemostas 1993; 3: 247-249
10 Powars D, Larsen R, Johnson J, Hulbert T, Sun T, Patch MJ, Francis R, Chan L. Epidemic meningococcemia and purpura fulminans with induced protein C deficiency. Clin Infect Dis 1993; 17: 254-261
11 Taylor FB, Chang Jr A, Hinshaw LB, Esmon CT, Archer LT, Beller BK. A model for thrombin protection against endotoxin. Thromb Res 1984; 36: 177-185
12 Taylor FB, Chang Jr A, Esmon CT, D’Angelo A, Vigano-D’Angelo S, Blick KE. Protein C prevents the coagulopathic and lethal effects of E coli infusion in the baboon. J Clin Invest 1987; 79: 918-925
13 Taylor F, Chang A, Ferrell G, Mather T, Catlett R, Blick K, Esmon CT. C4b-binding protein exacerbates the host response to Escherichia coli. Blood 1991; 78: 357-363
14 Grey S, Hau H, Salem HH, Hancock WW. Selective effects of protein C on activation of human monocytes by lipopolysac-charide, interferon-gamma, or PMA: Modulation of effects on CD11b and CD14 but not CD25 or CD54 induction. Transplant Proc 1993; 25: 2913-2914
15 Grey ST, Hancock WW. A physiologic anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes. J Immunol 1996; 156: 2256-2263
16 Gerson WT, Dickerman JD, Bovill EG, Golden E. Severe acquired protein C deficiency in purpura fulminans associated with disseminated intravascular coagulation: treatment with protein C concentrate. Pediatrics 1993; 91: 418-422
17 Rivard GE, David M, Farrell C, Schwarz HP. Treatment of purpura fulminans in meningococcemia with protein C concentrate. J Pediatr 1995; 126 (04) 646-652
18 Rivard GE, David M, Farrell C, Gerson W, Dickerman JD, Bovill EG, Schwarz HP. Treatment of purpura fulminans in meningococcemia with protein C concentrate. [Abstract] Thromb Haemost 1993; 69: 2338
19 Esmon CT, Schwarz HP. An update on clinical and basic aspects of the protein C anticoagulant pathway. Trends Cardiovasc Med 1995; 5: 141-148
20 Coughlin SR. Thrombin receptor function and cardiovascular disease. Trends Cardiovasc Med 1994; 4: 77-83
21 Fukudome K, Esmon CT. Identification, cloning and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 1994; 269: 26486-26491
22 Bangalore N, Drohan WN, Orthner CL. High affinity binding sites for activated protein C and protein C on cultured human umbilical vein endothelial cells. Independent of protein S and distinct from known ligands. Thromb Haemostas 1994; 72 (03) 465-474
23 Fukudome K, Kurosawa S, Steams-Kurosawa DJ, He X, Rezaie AR, Esmon CT. The endothelial cell protein C receptor: Cell surface expression and direct ligand binding by the soluble receptor. J Biol Chem 1996; 271: 17491-17498
24 Esmon CT, Simionescu N, Simionescu M. editors. Endothelial cell biology. New York: Plenum Publishing, Corp; 1988. 09. Assembly and function of the protein C anticoagulant pathway on endothelium,p. 191-206
25 Esmon NL. Thrombomodulin. Sem Thromb Hemost 1987; 13: 454-463
26 Steams-Kurosawa DJ, Kurosawa S, Mollica JS, Ferrell GL, Esmon CT. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Nati Acad Sci (USA) 1996; 93: 10212-10216
27 Mathews II, Padmanabhan KP, Tulinsky A. Structure of a nonadecapeptide of the fifth EGF domain of thrombomodulin complexed with thrombin. Biochemistry 1994; 33: 13547-13552
28 Stubbs MT, Oschkinat H, Mayr I, Huber R, Angliker H, Stone SR, Bode W. The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur J Biochem 1992; 206: 187-195
29 Rydel TJ, Ravichandran KG, Tulinsky A, Bode W, Huber R, Roitsch C, Fenton II JW. The structure of a complex of recombinant hirudin and human a-thrombin. Science 1990; 249: 277-280
30 Mathews II, Padmanabhan KP, Ganesh V, Tulinsky A, Ishii M, Chen J, Turck CW, Coughlin SR, Fenton JW. Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. Biochemistry 1994; 33: 3266-32679
31 Ye J, Esmon NL, Esmon CT, Johnson AE. The active site of thrombin is altered upon binding to thrombomodulin: Two distinct structural changes are detected by fluorescence, but only one correlates with protein C activation. J Biol Chem 1991; 266: 23016-23021
32 Mather T, Oganessyan V, Hof P, Huber R, Foundling S, Esmon C, Bode W. The 2.8 Å crystal structure of Gla-domainless activated protein CEMBO J. 1996; 15: 6822-6831
33 Brinkhous KM, Sigman JL, Read MS, Stewart PF, McCarthy KP, Timony GA, Leppanen SD, Rup B J, Keith JC, Garzone Jr PD. et al Recombinant human factor IX: Replacement therapy, prophylaxis, and pharmacokinetics in canine hemophilia B. Blood 1996; 88: 2603-2610
34 Cheung WF, van den Born J, Kuhn K, Kjellen L, Hudson BG, Stafford DW. Identification of the endothelial cell binding site for factor IX. Proc Natl Acad Sci (USA) 1996; 93: 11068-11073
35 Laszik Z, Esmon CT. The newly identified protein C receptor is present primarily on vascular endothelium of large vessels: Implications for the control of the protein C pathway. [In Press] J Clin Invest. 1997
36 Ding W, Gu JM, Fukudome K, Laszik Z, Grammas P, Esmon CT. Upregulation of the message for rodent endothelial cell protein C receptor (EPCR) by endotoxin and thrombin. [Abstract] Circulation 1996; 94: 1694